• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Myelodysplastic syndrome successfully treated with adalimumab.

作者信息

Prica Anca, Buckstein Rena

机构信息

Sunnybrook Health Sciences Centre/Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada

Sunnybrook Health Sciences Centre/Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada.

出版信息

J Clin Oncol. 2015 Jan 10;33(2):e4-6. doi: 10.1200/JCO.2013.49.4948. Epub 2014 Feb 24.

DOI:10.1200/JCO.2013.49.4948
PMID:24567429
Abstract
摘要

相似文献

1
Myelodysplastic syndrome successfully treated with adalimumab.
J Clin Oncol. 2015 Jan 10;33(2):e4-6. doi: 10.1200/JCO.2013.49.4948. Epub 2014 Feb 24.
2
Hematopoietic growth factors in myelodysplastic syndromes.骨髓增生异常综合征中的造血生长因子。
Semin Oncol. 2011 Oct;38(5):635-47. doi: 10.1053/j.seminoncol.2011.04.014.
3
[Level of adalimumab and its antibody titers define the effectiveness of the biological (anticytokine) therapy in Crohn's disease].阿达木单抗水平及其抗体滴度决定了克罗恩病生物（抗细胞因子）治疗的疗效
Eksp Klin Gastroenterol. 2013(7):18-22.
4
Acute coronary syndrome in a Crohn's disease patient treated with adalimumab.使用阿达木单抗治疗的克罗恩病患者发生急性冠状动脉综合征。
J Crohns Colitis. 2013 Oct;7(9):e396. doi: 10.1016/j.crohns.2013.02.011. Epub 2013 Mar 21.
5
Development and validation of a model to predict platelet response to romiplostim in patients with lower-risk myelodysplastic syndromes.低危骨髓增生异常综合征患者血小板对罗米司亭反应预测模型的开发与验证
Br J Haematol. 2014 Nov;167(3):337-45. doi: 10.1111/bjh.13037. Epub 2014 Jul 14.
6
Adalimumab as second line anti-tumour necrosis factor alpha therapy for Crohn's disease: A single centre experience.阿达木单抗作为二线抗肿瘤坏死因子 α 治疗克罗恩病：单中心经验。
J Crohns Colitis. 2011 Aug;5(4):324-31. doi: 10.1016/j.crohns.2011.02.007. Epub 2011 Mar 10.
7
Darbepoetin alfa for anemia with myelodysplastic syndrome.聚乙二醇化促红细胞生成素α用于治疗骨髓增生异常综合征所致贫血
Expert Rev Hematol. 2015 Apr;8(2):139-46. doi: 10.1586/17474086.2015.1000854. Epub 2015 Jan 12.
8
Effectiveness and safety of local adalimumab injection in patients with fistulizing perianal Crohn's disease: a pilot study.局部阿达木单抗注射治疗肛瘘型肛周克罗恩病的有效性和安全性：一项初步研究。
Dis Colon Rectum. 2012 Aug;55(8):870-5. doi: 10.1097/DCR.0b013e31825af532.
9
A retrospective cohort study to assess the impact of therapeutic substitution of darbepoetin alfa for epoetin alfa in anemic patients with myelodysplastic syndrome.一项回顾性队列研究，旨在评估在骨髓增生异常综合征贫血患者中用达贝泊汀α替代依泊汀α进行治疗的影响。
J Support Oncol. 2005 Nov-Dec;3(6):419-26.
10
[Development trend in new therapeutic approaches for anemia].[贫血新治疗方法的发展趋势]
Nihon Rinsho. 2008 Mar;66(3):569-74.

引用本文的文献

1
Novel Combination of Erythropoietin and Romiplostim to Treat Chemotherapy-Induced Anemia and Thrombocytopenia via Pharmacodynamic Interaction on Hematopoietic Stem and Progenitor Cells.促红细胞生成素与罗米司亭的新型组合通过对造血干细胞和祖细胞的药效学相互作用治疗化疗引起的贫血和血小板减少症。
ACS Pharmacol Transl Sci. 2023 Nov 15;6(12):1884-1897. doi: 10.1021/acsptsci.3c00194. eCollection 2023 Dec 8.
2
Scaling Pharmacodynamics from Rats to Humans to Support Erythropoietin and Romiplostim Combination Therapy to Treat Erythropoietin-Resistant Anemia.将药效学从大鼠扩展至人类以支持促红细胞生成素和罗米司亭联合疗法治疗促红细胞生成素抵抗性贫血。
Pharmaceutics. 2023 Jan 19;15(2):344. doi: 10.3390/pharmaceutics15020344.
3
Trial Watch: Immunotherapy plus radiation therapy for oncological indications.
试验观察：免疫疗法联合放射疗法用于肿瘤适应症
Oncoimmunology. 2016 Jul 25;5(9):e1214790. doi: 10.1080/2162402X.2016.1214790. eCollection 2016.